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Abstract: Temporomandibular joint (TMJ) arthritis causes severe debilitation and has few treatment options. Here, 
we found a small molecule, DNA methyltransferase 3B (Dnmt3b), as a putative therapeutic target, partially rescued 
osteoarthritic phenotype. Dnmt3b was detected differentially expressed in cell zones of mandibular condylar car-
tilage and the expression of Dnmt3b decreased in the progression of TMJ osteoarthritis. Dnmt3b deficiency using 
conditional knockout mice led to the onset of osteoarthritis-like conditions including cartilage clefts, cartilage ma-
trix loss and premature chondrocyte hypertrophy, which suggested that Dnmt3b functioned as a osteoarthritis sup-
pressor. Dnmt3b gain-of-function in TMJ stem/progenitor cells showed increases in collagen type II but decreases 
in collagen type X, whereas Dnmt3b knockdown had opposite effects with attenuated collagen type II but increased 
collagen type X. Dnmt3b acted via Wnt/β-catenin signaling and Dnmt3b regulated TMJ stem/progenitor cells dif-
ferentiation by inducing their premature progression towards hypertrophic chondrocytes through β-catenin trans-
nucleation and activation. Finally, local Dnmt3b delivery partially rescued cartilage degradation in experimentally 
induced osteoarthritis. Thus, novel molecules in articular cartilage, such as Dnmt3b, may have therapeutic effects 
for TMJ osteoarthritis.
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Introduction
The temporomandibular joint (TMJ) is a unique 
synovial articulation that controls jaw move-
ments to enable us to masticate and speak. 
TMJ osteoarthritis (OA) is a common degenera-
tive joint disease that causes orofacial pain 
and mandibular movement dysfunction, result-
ing in disability in normal daily activities [1]. The 
major characteristic of TMJ-OA is abnormal 
hypertrophic differentiation of articular chon-
drocytes, leading to progressive degeneration 
of cartilage and pathologic change of subchon-
dral bone [2]. Although there are ongoing 
efforts to study the pathogenesis of TMJ-OA 
and to develop potential therapeutic interven-
tion impeding TMJ-OA progression [3], the un- 
derlying cellular and molecular mechanisms of 
OA are still unclear.
Epigenetics, the study of changes in organisms 
caused by modification of gene expression 
without alteration in DNA sequence, is one of 
the fastest-growing fields in biomedical rese- 
arch [4, 5]. DNA methylation is the first recog- 
nized and most well characterized epigenetic 
modification that plays crucial roles in multiple 
biological processes [6, 7]. In mammalian cells, 
DNA methylation involves the addition of meth- 
yl group to DNA at the C5 position of CpG di- 
nucleotides. Methylation of specific CpG sites 
in the promoter region of genes typically results 
in silencing of gene expression [8, 9]. During 
development and differentiation, alterations in 
the DNA methylation that can switch genes on 
or off play a crucial role in the generation of 
tissue-specific gene expression profiles. 
DNA methylation are controlled at several dif-
ferent levels and carried out by a family of en- 
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zymes called DNA methyltransferase (DNM- 
Ts), including Dnmt1, Dnmt3a and Dnmt3b 
[10]. DNMTs are required for maintenance and 
establishment of DNA methylation patterns 
and essential for development and homeos- 
tasis [11, 12]. Aberrant DNA methylation ca- 
uses multiple diseases including osteoarthri- 
tis [13]. Genome-wide DNA methylation studi- 
es have identified significant DNA methylation 
in osteoarthritic chondrocytes [14-16]. Despite 
their implications in osteoarthritis, the roles of 
DNMTs in the onset and development of ost- 
eoarthritis are elusive. Furthermore, little is kn- 
own whether DNMTs may rescue osteoarthritis 
phenotype, given their involvement in the onset 
of the diseases. In the present study, we dis-
covered that Dnmt3b differentially expressed 
during condylar cartilage chondrogenesis and 
expression of Dnmt3b decreased in the pro-
gression of TMJ osteoarthritis. We show that 
Dnmt3b not only plays crucial roles in the 
pathogenesis of osteoarthritis, but also partial-
ly rescues disease progression using multiple 
stem/progenitor cells and in vivo models.
Materials and methods
Mice
All animal handling and procedures in this stu- 
dy were performed in accordance with instit- 
utional guidelines, and approved by Columbia 
University Institutional Animal Care and Use 
Committee (IACUC). Postnatal-7-day and 12- 
week-old CD-1 mice were purchased from Ch- 
arles River Laboratory. The conditional Dnmt- 
3b knockout mice Agc1CreERT2; Dnmt3bf/f (Dn- 
mt3b-/-) were given as generous gifts from the 
laboratory of Dr. Regis J O’Keefe. Dnmt3b gene 
knockout is chondrocyte specific and tamo- 
xifen (TM)-inducible, generated by crossing the 
Agc1CreERT2 mice with the Dnmt3bf/f mice. Dn- 
mt3bf/f mice and Cre-positive and negative con-
trol mice were administered TM (1 mg/10 g 
body weight, IP, daily for 5 days) at 2 month of 
age. Mice were killed 5 month after TM induc-
tion for histological analysis. 
Surgically induced TMJ-OA rabbit model
TMJ-OA was surgically induced in 3-4 month 
old New Zealand white rabbits as previously 
described [17]. Briefly, TMJ condyle and disc 
were exposed by surgical incision superior to 
the zygomatic process under general anaes-
thesia. A 2.5 mm defect was created using a 
punch biopsy in the TMJ disc. No disc attach-
ments were severed and the surgical incision 
was closed with sutures. Sham operation was 
performed on the contralateral side, whereby 
the TMJ disc was accessed, but without any 
perforation. Rabbits were sacrificed at 4 and 8 
weeks after surgery for immunohistochemi- 
stry. 
Chemically induced TMJ-OA rat model
12-weeks-old Spargue-Dawley rats were deeply 
anesthetized with 3-5% isoflurane in 100% O2 
(1 L/min) and randomly assigned to 3 groups (n 
= 6/group). The synovial compartments of bilat-
eral TMJ were injected by 50 ul saline for sham 
group, or 0.5 mg monosodium iodoacetate 
(MIA, Sigma) dissolved in 50 ul saline for OA 
group, or 0.5 mg/50 ul monosodium iodoace-
tate and 100 ul Dnmt3b virus (a total of 1 × 106 
infectious particles) for treatment group, using 
a 26-gauge 0.5-inch needle. Rats were sacri-
ficed at 4 weeks postoperatively, and TMJ tis-
sues were harvested and processed for histo-
logical analysis. 
Histochemical analysis and quantificational 
evaluation
TMJ specimens from experimental animals 
were dissected, fixed overnight in 10% forma-
lin, decalcified with EDTA, dehydrated and 
embedded in paraffin. 5 μm-thick tissue se- 
ctions were cut and collected on slides. Se- 
ctions were stained with HE and Safranin-O 
using standard protocol for histological obser-
vations. For immunohistochemistry, HRP-DAB 
Cell & Tissue Staining Kit (R&D Systems) was 
used according to the manufacturer’s instruc-
tions. Briefly, tissue sections were deparaf-
finized, rehydrated and heat-retrieved, followed 
by blocking with appropriate serum and incub- 
ation with primary antibodies: Dnmt1 (ab199- 
05 1:200), Dnmt3a (ab23565, 1:200), Dnmt3b 
(ab2851 1:400), Ki67 (ab15580 1:200), Col II 
(ab34712 1:400), Col X (ab58632 1:200), 
β-catenin (ab16051 1:400) overnight at 4°C. 
After PBS wash, sections were incubated with 
HRP conjugated secondary antibodies. Immu- 
noreactivity was detected with DAB followed 
by counterstaining with hematoxylin. Sections 
were mounted and visualized under micros- 
cope. 
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Quantitative histological assessments were 
done by Image J. All parameters were deter-
mined and averaged from three sections per 
mouse and five mice per group. Staining inten-
sity of Dnmt3b was analyzed using color decon-
volution feature of Image J. Safranin-O positive 
staining area was outlined and quantified on 
projected images of each histologic section to 
determine articular cartilage area and thick-
ness. To analyze the proliferation of chondro-
cytes, the number of Ki67 immunopositeve 
cells was counted per unit area. To quantify 
changes in hypertrophic chondrocytes, the 
immunopositive area of Col II and Col X were 
measured from representative sections of each 
group. 
Cell isolation and culture
Progenitor/stem cells were isolated from man-
dibular condylar cartilages of 10-week-old 
mice. Cartilage tissues were dissected with fine 
forceps under the microscope, and enzymati-
cally digested with 3 mg/ml collagenase type I 
and 4 mg/ml dispase (Gibco) in 1X PBS for 3 
hours at 37°C. The dissociated single cell sus-
pension was filtered through a nylon mesh (70 
mm pore size, BD Falcon) and cultured in basal 
medium consisting of a-MEM supplemented 
with 10% FBS and antibiotics. After one week, 
cells were passaged and maintained with medi-
um change every 2-3 days.
Micromass culture
Cells were harvested and resuspended at a 
density of 2*107 cells/ml. 5 ul droplets of cell 
solution were seeded in the center of 12-well 
plate. Following incubation at 37°C for 2 h, 
micromass was generated and adhered to the 
culture surface. 1 ml chondrogenic differenti- 
ation media (Invitrogen) were then added and 
changed every 2-3 days. Micromasses were 
harvested at 1 w, 2 w and 3 w for Safranin O 
and Alcian Blue staining, gene expression anal-
ysis and protein detection.
Overexpression and knockdown of Dnmt3b in 
progenitor/stem cells
For Dnmt3b overexpression, pWPI lentiviral 
vector (Plasmid #12254, Addgene) encoding 
Dnmt3b gene was constructed. pWPI or pWPI-
Dnmt3b, pMD2.G (Plasmid #12259, Addgene) 
and psPAX2 (Plasmid #12260, Addgene) vec-
tors were co-transfected into 293T cells using 
Calcium Phosphate Transfection Kit per manu-
facturer’s protocol (Invitrogen). Viral harvest 
was collected 48-72 h post-transfection and 
filtered with 0.45 μm membrane. TMJ progeni-
tor/stem cells were infected either with pWPI 
lentivirus (Control group) or pWPI-Dnmt3b lenti-
virus (Dnmt3b overexpression group), with 
addition of 8 ug/ml polybrene to increase the 
infection efficiency. Infected cells were sorted 
by FACS based on GFP reporter gene expres-
sion and were further passaged for following 
experiments. For knocking-down Dnmt3b, TMJ 
progenitor/stem cells were transfected by add-
ing the Dnmt3b shRNA lentiviral particles fol-
lowing manufacturer’s protocol (Santa Cruz). 
Cells stably express the shRNA of Dnmt3b 
(Dnmt3b knockdown group) were sorted by 
addition of 6 ug/ml puromycin after 3-5 days 
and expanded for further experiments.
Real-time RT-PCR
Total RNA was extracted using Trizol (Invitrogen) 
and converted to cDNA with iScriptTM cDNA 
Synthesis Kit (Bio-Rad) according to manufac-
turer’s protocol. Primers were designed as fol-
lows: Col II, forward 5’-AGCAAGAGCAAGGAAA- 
AGAAA-3’, reverse 5’-GTGGACAGTAGACGGAG- 
GAAA-3’; Col X, forward 5’-TTTCTGCTGCTAATG- 
TTCTTG-3’, reverse 5’-AATCCCTTTACTCTTTATG- 
GC-3’; Dnmt3b, forward 5’-CTAAGAGCGTCAGT- 
ACCCCATC-3’, reverse 5’-CACGAGGTCACCTATT- 
CCAAA-3’; Gapdh, forward 5’-AATGGATTTGGAC- 
GCATTGGT-3’, reverse 5’-TTTGCACTGGTACGTG- 
TTGAT-3’. Real-time PCR was performed using 
SYBR method by a 7500 Real-Time PCR system 
(Applied Biosystems). Gene expressions were 
normalized to Gapdh and analyzed by 2ΔΔCt 
method. The experiments were repeated at 
least three times.
Western blot
Total protein was extracted in RIPA Lysis Buffer 
(Thermo Scientific) supplied with Protease/
Phosphatase Inhibitor Cocktail (Cell Signaling 
Technology). Whole lysate protein concentra-
tions were determined with BCA Protein Assay 
Reagent (Thermo Fisher Scientific). Proteins 
were separated by a NuPAGE Novex 4-12% Bis-
Tris Protein Gel (Invitrogen), transferred onto 
nitrocellulose membrane (Bio-Rad) and immu-
noblotted with anti-Dnmt3b (Abcam 1:200) 
antibody. Bound antibody detection was visual-
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ized by IR fluorescence & Odyssey using corre-
sponding secondary antibody (LI-COR).
Luciferase reporter assay
A total of 105 cells were cotransfected with 3 ug 
Firefly luciferase reporter plasmid Topflash and 
10 ng Renilla luciferase control plasmid by 
Lipofectamine 2000 (Invitrogen). After 48 h 
transfection, cells were lysed and the transcr- 
iptional activity of β-catenin was measured by 
using Dual-Luciferase® Reporter Assay Syst- 
em (Promega) per manufacturer’s instructions. 
Relative luciferase activity was indicated by 
normalizing Firefly luciferase activity against 
Renilla luciferase activity. 
Immunocytofluorescence
Cells grown on coverslips were fixed with 4% 
paraformaldehyde for 15 min, treated with 
0.5% Triton X-100, and blocked with blocking 
buffer for 1 h, followed by incubation with 
β-catenin antibody (Abcam 1:200) overnight 
at 4°C. After PBS washing, cells were incuba- 
ted with FITC-conjugated secondary antibody 
Figure 1. Dnmt3b expression patterns in normal and osteoarthritic TMJ condyle. A-F. Immunohistochemistry of Dn-
mts (Dnmt1, Dnmt3a, Dnmt3b) showed similar expression pattern but different expression intensity in TMJ condyle 
of postnatal-day-7 and 12-week-old mice. In P7 mice, Dnmts were expressed in articular and hypertrophic zones 
during condylar cartilage development. In 12-week-old mice, Dnmts were expressed throughout all the condylar car-
tilage. Dnmt3b was strongly expressed, while Dnmt1 and Dnmt3a were moderately expressed. G-J. Immunohisto-
chemistry of Dnmt3b in 3-4 month old rabbit TMJ condyle at 4 weeks and 8 weeks after TMJ-OA or Sham operated. 
Dnmt3b expression was decreased during TMJ-OA cartilage degeneration. K. Quantification of Dnmt3b expression. 
Scale bar = 100 µm.
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(Invitrogen) for 30 min. Coverslips were moun- 
ted with mounting medium containing DAPI 
(Abcam) and fluorescent images were observ- 
ed by fluorescence light microscope (Olympus).
Figure 2. Dnmt3b deficiency induced osteoarthritis phenotype. A-F. Cartilage degeneration including cartilage cleft 
(dotted frame), loss of proteoglycan were observed in Dnmt3b-/- mice, indicated by HE and Safranin-O staining. 
G-L. Immunohistochemistry of Ki67, Col II and Col X in TMJ condyle from WT and Dnmt3b-/- mice. M-P. Quantifica-
tion assay compared between WT and Dnmt3b-/- mice. Safranin-O positive area decreased 60%, Ki67 expression 
increased 3 fold, Col II ex pression decreased 20% and Col X expression increased 1.8 fold in Dnmt3b-/- mice com-
pared to the age-matched WT mice. Scale bar = 100 µm.
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Statistical analysis
All experiments were performed at least three 
times. All quantitative data presented as mean 
± SD were statistically analyzed by Student’s 
t-test or one-way ANOVA using SPSS software. 
Any p values <0.05 were considered statistically 
significant.
Results
Dnmt3b expression patterns and potential 
roles in experimentally induced osteoarthritic 
In neonatal stage at P7, Dnmt1, Dnmt3a and 
Dnmt3b were detected in articular and hyper-
trophic zones of wild-type condyles, but absent 
in the mature zone (Figure 1A-C). Dnmt3b 
showed particular robust expression (Figure 
1C). In the adult of 12-week-old mice, Dnmts 
were expressed throughout cartilage, again 
with Dnmt3b robustly expressed (Figure 1F), 
whereas Dnmt1 and Dnmt3a only modestly 
expressed (Figure 1D, 1E). Given Dnmt3b’s 
robust expression in both neonatal and adult 
stages (Figure 1C, 1F), we further interrogated 
its expression in our existing induced osteoar-
thritis rabbit model in vivo by surgical perfora-
tion of the articular disc dinucleotides [6, 7]. 
Strikingly, Dnmt3b diminished postoperatively 
in 4- and 8-wks, coinciding with development of 
osteoarthritis phenotype (Figure 1I, 1J) in com-
parison to controls compared to the sham 
group (Figure 1G, 1H). Quantitatively, Dnmt3b 
expression showed significantly decreases by 4 
wks following experimentally induced OA and 
diminished by 8 wks (Figure 1K). Thus, Dnmt3b 
likely plays significant roles in cartilage devel-
opment and OA onset.
Dnmt3b deficiency induced osteoarthritis phe-
notype 
We then adopted Agc1-Cre-ERT2; Dnmt3bf/f 
mice (Dnmt3b-/-) to appreciate Dnmt3b’s roles 
in cartilage degeneration. At 5 months after TM 
induction, osteoarthritic phenotype was readily 
observed in TMJ condylar cartilage, including 
surface fibrillation and vertical clefts in 
Dnmt3b-/- mice (Figure 2A-D). Loss of glycos-
aminoglycans was observed in Dnmt3b-/- con-
dyles relative to controls (Figure 2E, 2F), and 
quantitatively verified in Figure 2M. Ki67 posi-
tive cells showed marked increases in Dnmt3b-/- 
condyles, relative to the control (Figure 2G, 
2H), as quantitatively verified in Figure 2N. 
Proteoglycan loss is associated with decreased 
Col II (Figure 2I, 2J) as quantitatively verified in 
Figure 2O, but increased Col X (Figure 2K, 2L), 
as quantitatively verified in Figure 2P.
Dnmt3b inhibited chondrogenic differentiation 
of TMJ progenitor/stem cells 
We then isolated stem/progenitor cells from 
TMJ cartilage of 10-week-old mice [18-20] and 
manipulated Dnmt3b expression to appreciate 
how it may mediate cell behavior. We induced 
TMJ stem/progenitor cells to undergo chondro-
genesis in micromass culture system (Figure 
3A). TMJ progenitor/stem cells formed a carti-
lage-like sphere enriched with abundant carti-
lage matrix (Figure 3B) and the mRNA and pro-
tein expressions of Col II and Col X were signi- 
ficantly upregulated during chondrogenic diff- 
erentiation (Figure 3C-F). Following confirma-
tion of Dnmt3b overexpressed and knockdo- 
wn by qPCR and Western-blot analyses (Figure 
3G, 3H), we first found that Dnmt3b overex-
pression upregulated Col II but attenuated Col 
X (Figure 3I, 3J). Conversely, Dnmt3b knock-
down enhanced chondrogenic hypertrophy by 
downregulation of Col II but upregulation of Col 
X (Figure 3K, 3L).
Dnmt3b regulated chondrogenic differentia-
tion through Wnt/β-catenin signaling pathway
Given the importance of Wnt signaling in chon-
drogenic differentiation and osteoarthritis [21], 
we probed Wnt/β-catenin and surprisingly fo- 
und that Dnmt3b overexpression decreased 
Topflash luciferase activity and suppressed β- 
catenin nuclear translocation, whereas Dnmt- 
3b knockdown increased Topflash luciferase 
activity and β-catenin nuclear translocation 
relative to controls (Figure 4A, 4B). Additionally, 
β-catenin expression was enhanced in Dnm- 
t3b-/- mice compared to controls (Figure 4C). 
Accordingly, we proposed a model in which 
Dnmt3b attenuation induced premature cho- 
ndrogenic hypertrophy through Wnt/β-catenin 
activation and onset of TMJ osteoarthritis 
(Figure 4D).
Local Dnmt3b delivery partially rescued ex-
perimentally induced osteoarthritis
To appreciate Dnmt3b putative roles in ost- 
eoarthritis, we adopted an existing chemically 
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Figure 3. Dnmt3b inhibited TMJ progenitor/stem cell differentiation. A. TMJ progenitor/stem cells were isolated from mandibular condylar cartilages of 10-week-old 
mice and cultured in vitro. B. TMJ progenitor/stem cells were micromass cultured followed by chondrogenic differentiation, assayed by Safranin-O and Alcin blue 
staining at 1 w, 2 w and 3 w. Scale bar = 2 mm. C-F. Col II, Col X and Dnmt3b mRNA expression and Dnmt3b protein expression were upregulated during chondro-
genic differentiation, detected by qRT-PCR and western blot analysis. G, H. TMJ progenitor/stem cells were infected with control, Dnmt3b overexpression (Dnmt3b-
Ov) or Dnmt3b shRNA (Dnmt3b-Kd) lentivirus, followed by cell line selection using FACS or puromycin method. Scale bar = 500 µm. I, J. Dnmt3b overexpression and 
knockdown efficiency were determined at the mRNA and protein levels. K, L. Dnmt3b knockdown enhanced chondrogenic hypertrophy, by downregulation of Col II 
and upregulation of Col X, while Dnmt3b overexpression had the opposite effects.
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Figure 4. Dnmt3b regulated chondrogenic differentiation through Wnt/β-catenin signaling pathway. A. Dnmt3b overexpression in TMJ progenitor/stem cells led 
to decreased Topfalsh luciferase activity while Dnmt3b knockdown showed significantly stronger Topfalsh luciferase activity compared to the control group. B. 
β-catenin nuclear translocalization was suppressed by Dnmt3b overexpression and activated by Dnmt3b knockdown, detected by immunocytofluorescence. C. 
β-catenin signal was much stronger in condylar cartilage of Dnmt3b-/- mice than WT mice. D. A proposed diagram for the role of Dnmt3b in TMJ-OA development. 
Inhibition of Dnmt3b induced TMJ-OA by enhancing chondrogenic hypertrophy through activation of β-catenin signaling pathway. Scale bar = 100 µm.
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Figure 5. Local Dnmt3b delivery partially rescued experimentally induced osteoarthritis. A-L. Representative staining of rat condylar cartilage with HE, Safranin-O 
and immunostaining of Col II and Col X. Rats were treated with PBS (Sham group), MIA (OA group), or MIA+Dnmt3b (Treatment group) in the synovial compartment 
of TMJ. MIA induced OA phenotype with thinner cartilage layer, loss of proteoglycan, downregulated Col II and upregulated Col X, which was attenuated by treatment 
of Dnmt3b. Scale bar = 200 µm. M-P. Quantification assay of cartilage thickness, Safranin-O staining and immunostaining of Col II and Col X.
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induced experimental rat OA model by intra-
articular monosodium iodoacetate (MIA) injec-
tion [22], with intra-articular PBS injection as a 
control (Figure 5A, 5B). Indeed, intra-articular 
MIA injection led to chemically induced OA with 
cartilage degeneration in 4 wks, characterized 
by reduced cartilage thickness compared to 
the sham (Figure 5B, 5M). Contrastingly, local 
virus delivery with Dnmt3b partially rescued 
cartilage thickness (Figure 5C), as quantitative-
ly verified in Figure 5M. Safranin-O positive pro-
teoglycans were present in PBS injected con-
trol cartilage (Figure 5D), markedly lost in MIA 
injected OA cartilage (Figure 5E), and partially 
restored in Dnmt3b injected sample (Figure 
5F), as quantitatively verified in Figure 5N. In 
parallel, Type II collagen was abundant in PBS 
injected control cartilage (Figure 5G), markedly 
lost in MIA injected OA cartilage (Figure 5H), 
and partially restored in Dnmt3b injected sam-
ple (Figure 5I), as quantitatively verified in 
Figure 5O. Conversely, Type X collagen was 
scarce in PBS injected control cartilage (Figure 
5J), markedly enhanced in MIA injected OA car-
tilage (Figure 5K), and only modestly expressed 
in Dnmt3b injected sample (Figure 5L), as 
quantitatively verified in Figure 5P.
Discussion
Osteoarthritis (OA) is a degenerative joint dis-
ease characterized by progressive loss of car- 
tilage matrix, cartilage clefts and subchondral 
bone breakdown. TMJ arthritis remains a poorly 
understood cluster of diseases, and hence, 
clinical management is palliative. Epigenetic 
changes occur during chondrogenesis and in 
osteoarhritis [23]. In the present study, we 
identified DNA methyltransferase 3B (Dnmt3b) 
as key regulator in chondrogenic differentiati- 
on and TMJ OA patheogenesis. We showed 
that Dnmt3b deficiency enhanced chondrocy- 
te proliferation and premature hypertrophy of 
TMJ stem/progenitor cells and induced the 
onset of TMJ OA, indicating that Dnmt3b mai- 
ntains chondrocyte homeostasis and inhibits 
pathological hypertrophic differentiation. We 
also showed for the first time that DNA methyl-
transferase 3B (Dnmt3b), as a putative thera-
peutic target, partially rescued osteoarthritic 
phenotype. 
Wnt/β-catenin signaling is critically involved in 
cartilage homeostasis and associated with 
osteoarthritis pathogenesis [24, 25]. Upregu- 
lation of Wnt/β-catenin signaling in articular 
chondrocytes of knee joint or TMJ enhanced 
hypertrophic differentiation and induced the 
onset of OA [26, 27]. It was reported that 
Dnmt3b interacted with Wnt/β-catenin signal-
ing in hematopoietic stem cells [28], providing 
us new insights into a possible mechanism 
behind the relationship between Dnmt3b and 
Wnt/β-catenin signaling. In the present study, 
we found that Dnmt3b attenuation activated 
β-catenin nuclear translocation both in vitro 
and in vivo, providing clues to the importance of 
Wnt signaling in TMJ arthritis. Further investiga-
tions are warranted to unveil the DNA methyla-
tion of Wnt/β-catenin signalling pathway relat-
ed genes in our further prospective studies.
TMJ-OA animal models are well accepted in 
investigating the pathophysiology during the 
progression of TMJ-OA [3, 22, 29]. In this study, 
we generated biochemically induced TMJ-OA 
model and treated by local delivery with 
Dnmt3b. We found that Dnmt3b prevented 
TMJ-OA progression by repressing chondrocyte 
hypertrophic differentiation, suggesting that 
Dnmt3b played a protective role in cartilage 
maintenance and promoted cartilage repair 
during TMJ-OA development. Currently, there 
are several studies of treatment strategies for 
TMJ-OA. For example, intra-articular injection of 
TGF-β1 was reported to increase the cartilage 
matrix and protect subchondral bone form 
damage in TMJ-OA [30]. A comparative study 
demonstrated that intra-articular injection of 
NEL-like molecule-1 (Nell-1) into the TMJ had 
chondroprotective effects by upregulation of 
type II collagen and aggrecan [31]. Our study 
provided new insight into Dnmt3b as an alter-
native therapeutic intervention for TMJ-OA and 
the benefits of this treatment remain to be fur-
ther evaluated. 
In summary, Dnmt3b appears to play important 
roles in cartilage homeostasis and the onset 
and progression of osteoarthritis. Dnmt3b, as a 
putative therapeutic target, partially rescued 
osteoarthritic phenotype.
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